Figure 3

Kaplan-Meier survival plot for samples with differential ZNF217 gene expression. ZNF217 levels correlate with patient survival (Rembrandt database of the National Cancer Institute). There were only four patients with more than twofold ZNF217 downregulation in gliomas. P<0.001 with ZNF217 high vs intermediate.